Illinois Municipal Retirement Fund Takes Position in Revvity, Inc. (NYSE:RVTY)

Illinois Municipal Retirement Fund bought a new position in shares of Revvity, Inc. (NYSE:RVTY) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 11,360 shares of the company’s stock, valued at approximately $1,242,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of RVTY. New York State Common Retirement Fund purchased a new position in shares of Revvity in the 4th quarter valued at about $10,948,000. 1900 Wealth Management LLC purchased a new position in Revvity in the fourth quarter worth approximately $355,000. Garrison Asset Management LLC acquired a new position in Revvity during the 4th quarter worth approximately $2,373,000. Duality Advisers LP purchased a new stake in shares of Revvity in the 4th quarter valued at approximately $705,000. Finally, Handelsbanken Fonder AB acquired a new stake in shares of Revvity in the 4th quarter valued at $2,870,000. 86.65% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts recently commented on RVTY shares. UBS Group downgraded shares of Revvity from a “buy” rating to a “neutral” rating and boosted their target price for the stock from $105.00 to $125.00 in a research note on Tuesday, January 16th. KeyCorp increased their price objective on Revvity from $110.00 to $126.00 and gave the company an “overweight” rating in a report on Friday, February 2nd. Barclays boosted their target price on Revvity from $92.00 to $105.00 and gave the stock an “equal weight” rating in a research note on Thursday, January 25th. Evercore ISI upgraded shares of Revvity from an “in-line” rating to an “outperform” rating and increased their price target for the company from $88.00 to $125.00 in a research note on Thursday, January 4th. Finally, Raymond James raised their price objective on shares of Revvity from $106.00 to $127.00 and gave the stock an “outperform” rating in a report on Friday, February 2nd. Six research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $118.91.

Insider Transactions at Revvity

In related news, insider Prahlad R. Singh sold 21,217 shares of the stock in a transaction on Monday, February 5th. The stock was sold at an average price of $104.28, for a total transaction of $2,212,508.76. Following the completion of the sale, the insider now directly owns 92,801 shares of the company’s stock, valued at $9,677,288.28. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Company insiders own 0.60% of the company’s stock.

Revvity Stock Performance

Shares of RVTY opened at $101.51 on Friday. Revvity, Inc. has a 12-month low of $79.50 and a 12-month high of $132.54. The company has a current ratio of 2.07, a quick ratio of 1.77 and a debt-to-equity ratio of 0.40. The firm has a market cap of $12.54 billion, a PE ratio of 18.46, a price-to-earnings-growth ratio of 2.66 and a beta of 1.09. The company’s 50 day simple moving average is $104.66 and its 200-day simple moving average is $101.40.

Revvity (NYSE:RVTY) last announced its earnings results on Thursday, February 1st. The company reported $1.25 EPS for the quarter, beating analysts’ consensus estimates of $1.15 by $0.10. Revvity had a net margin of 25.20% and a return on equity of 7.41%. The business had revenue of $695.90 million during the quarter. As a group, equities analysts predict that Revvity, Inc. will post 4.65 EPS for the current year.

Revvity Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, August 9th. Stockholders of record on Friday, July 19th will be issued a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.28%. The ex-dividend date is Friday, July 19th. Revvity’s payout ratio is currently 5.09%.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.